Insider Trading & Ownership - Avagliano Mark

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Avagliano Mark
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-01-03
Sale
2024-01-08
06:02 am
G1 Therapeutics Inc.GTHXAvagliano Mark
Chief Business Officer
4,081$3.0877$12,601207,234
(Direct)
View
2022-01-05
Sale
2022-01-05
8:24 pm
G1 Therapeutics Inc.GTHXAvagliano Mark
Chief Business Officer
1,445$10.61$15,33474,555
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-20
Option Award
2024-03-22
4:09 pm
N/A
N/A
G1 Therapeutics Inc.GTHXAvagliano Mark
Chief Business Officer
100,000$0217,834
(Direct)
View
2024-01-03
Option Award
2024-01-08
06:02 am
N/A
2034-01-03
G1 Therapeutics Inc.GTHXAvagliano Mark
Chief Business Officer
134,160$0207,234
(Direct)
View
2023-05-10
Option Award
2023-05-12
4:20 pm
N/A
N/A
G1 Therapeutics Inc.GTHXAvagliano Mark
Chief Business Officer
35,000$077,155
(Direct)
View
2023-01-03
Option Award
2023-01-05
8:25 pm
N/A
2033-01-03
G1 Therapeutics Inc.GTHXAvagliano Mark
Chief Business Officer
61,700$083,255
(Direct)
View
2022-01-03
Option Award
2022-01-05
8:24 pm
N/A
2032-01-03
G1 Therapeutics Inc.GTHXAvagliano Mark
Chief Business Officer
65,000$074,555
(Direct)
View
2021-01-04
Option Award
2021-01-05
6:10 pm
N/A
2031-01-04
G1 Therapeutics Inc.GTHXAvagliano Mark
Chief Business Officer
69,000$069,000
(Direct)
View
2020-02-06
Option Award
2020-02-07
4:15 pm
N/A
2030-02-06
G1 Therapeutics Inc.GTHXAvagliano Mark
Chief Business Officer
60,000$060,000
(Direct)
View
2019-07-29
Option Award
2019-07-30
4:29 pm
N/A
2029-07-29
G1 Therapeutics Inc.GTHXAvagliano Mark
Chief Business Officer
300,000$0300,000
(Direct)
View